Fund Holdings — Avoro Capital Advisors LLC

Total Portfolio Value
$7.73B
Total Bought
$1.44B
Total Sold
$977.85M
Net Transaction
+$458.76M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MADRIGAL PHARMACEUTICALS INC(MDGL)1,875,0001,833,000-42,000567,450840,72410.88%+273,274
UNIQURE NV(QURE)3,625,0004,444,444+819,44450,533259,4223.36%+208,890
ARROWHEAD PHARMACEUTICALS INC.(ARWR)10,600,00010,900,000+300,000167,480375,9414.86%+208,461
CENTESSA PHARMACEUTICALS PLC5,000,00010,808,080+5,808,08065,700262,0963.39%+196,396
MERUS N V3,155,5553,542,500+386,945165,982333,5264.31%+167,544
UNITED THERAPEUTICS CORP(UTHR)2,370,0002,022,222-347,778681,020847,73610.97%+166,716
ASCENDIS PHARMA(ASND)4,980,0005,110,000+130,000859,5481,015,91913.14%+156,371
STRUCTURE THERAPEUTICS INC.05,155,555+5,155,5550144,3561.87%+144,356
AVIDITY BIOSCIENCES INC7,050,0007,645,000+595,000200,220333,0934.31%+132,873
KRYSTAL BIOTECH INC(KRYS)2,660,0002,777,777+117,777365,644490,3616.34%+124,717
ARGENX SE(ARGX)1,175,000990,000-185,000647,684730,1849.45%+82,501
TOURMALINE BIO INC2,555,5552,555,555040,863122,2321.58%+81,369
KYMERA THERAPEUTICS INC(KYMR)6,555,5556,350,000-205,555286,084359,4104.65%+73,326
APELLIS PHARMACEUTICALS INC.
COM
12,222,22212,222,2220211,567276,5893.58%+65,022
OCULAR THERAPEUTIX INC(OCUL)7,400,00010,250,000+2,850,00068,672119,8231.55%+51,151
XENON PHARMACEUTICALS INC(XENE)5,400,0005,400,0000169,020216,8102.80%+47,790
VERA THERAPEUTICS INC(VERA)6,300,0006,210,000-90,000148,428180,4632.33%+32,035
89BIO INC6,750,0006,387,790-362,21066,28593,9011.21%+27,616
ORUKA THERAPEUTICS INC(ORKA)01,333,340+1,333,340025,6400.33%+25,640
TAYSHA GENE THERAPIES INC(TSHA)21,700,00021,700,000050,12770,9590.92%+20,832
AMICUS THERAPEUTICS INC.
COM
18,000,00015,025,000-2,975,000103,140118,3971.53%+15,257
SEPTERNA INC(SEPN)1,237,5001,337,500+100,00013,08025,1580.33%+12,078
TANGO THERAPEUTICS INC(TNGX)0545,000+545,00004,5780.06%+4,578
SOLENO THERAPEUTICS INC2,050,0002,577,777+527,777171,749174,2582.25%+2,509
MANNKIND CORP(MNKD)5,850,0004,468,877-1,381,12321,87923,9980.31%+2,119
AKERO THERAPEUTICS INC3,500,0003,955,555+455,555186,760187,8102.43%+1,050
WHITEHAWK THERAPEUTICS INC(WHWK)2,849,4022,849,40205,3285,4140.07%+85
ULTRAGENYX PHARMACEUTICAL INC(RARE)330,0000-330,00011,9990—-11,999
ALKERMES PLC(ALKS)2,900,0002,240,000-660,00082,96967,2000.87%-15,769
MONTE ROSA THERAPEUTICS INC(GLUE)3,725,0000-3,725,00016,8000—-16,800
BIOCRYST PHARMACEUTICALS INC(BCRX)4,500,0001,250,000-3,250,00040,3209,4880.12%-30,832
BLUEPRINT MEDICINES CORP375,0000-375,00048,0680—-48,067
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)4,150,0002,000,000-2,150,000195,88014,3400.19%-181,540
Page 1 of 1
Avoro Capital Advisors LLC — 13F Holdings — Q3 2025 | TickerTrail